Mark Dunnenberger, PharmD
New guidelines and technology can improve pharmacogenomics (PGx) implementation, resulting in better informed drug selection and dosing as well as fewer medical errors and preventable adverse events.
“Pharmacogenomics can be complicated, but clinical decision support [CDS] can help make it easier,” said Mark Dunnenberger, PharmD, the director of pharmacogenomics at NorthShore University HealthSystem, in Illinois.
Such help often is needed,